lung cancer

Views & Analysis

pharmaphorum_podcast-Episode-14-1200x675

AstraZeneca and lung cancer: the pharmaphorum podcast

This episode of the pharmaphorum podcast focuses on lung cancer, with AstraZeneca’s VP, global franchise head, Tagrisso TDR (Tumour Drivers and Resistance) Patrick Connor explaining why the

Views & Analysis

pharmaphorum_podcast-Episode-13-605x340-2

Lung cancer’s patient information gap: the pharmaphorum podc...

For episode 13 of the pharmaphorum podcast podcast I went to AstraZeneca’s London base to meet Paul Naish, who’s the company’s director of oncology advocacy and government affairs, to talk

News

AZ says recovery to continue to despite patent expiry and Br...

AstraZeneca has upped its revenue expectations following a strong second quarter, saying that sales of newer drugs will offset a major patent expiry and the impact of Brexit.

News